Skip to main content
. 2018 Jun 4;15(9):892–899. doi: 10.7150/ijms.24042

Figure 1.

Figure 1

(A-C) The proportion of CD8Ts in a recipient without graft dysfunction (A), a patient with graft dysfunction (B), and a recipient with immunosuppressant withdrawal (C). (D) Summary data showing the proportion of CD8Ts among groups. (E) CD8T proportions in relation to recovery of graft function in recipients with rejection. (F) CD8T proportions in patients with refractory graft dysfunction.